Literature DB >> 14600127

Prognostic relevance of rosette-like features in osteosarcoma.

K Okada1, T Hasegawa, R Yokoyama, Y Beppu, E Itoi.   

Abstract

AIMS: To clarify the prognostic relevance of rosette-like features and other clinicopathological and immunohistochemical variables in patients with osteosarcoma.
METHODS: Clinicopathological and immunohistochemical variables were analysed in 131 patients with non-metastatic high grade conventional osteosarcoma, with particular attention to the prognostic impact of rosette-like features.
RESULTS: Rosette-like features were present in 18 (14%) cases. Rosette-like features were significantly associated with the osteoblastic subtype, numerous osteoclast-like giant cells, moderate pleomorphism, frequent haemangiopericytoma-like vascular patterns, epithelioid cytological features, positive immunoreactivity for epithelial membrane antigen and CD56, and negative staining for cytokeratin. In a multivariate analysis, rosette-like features (relative risk (RR), 3.8), a poor chemotherapy effect (RR, 2.9), and a tumour size of 10 cm or more (RR, 2.8) were identified as unfavourable prognostic factors.
CONCLUSIONS: Rosette-like features can easily be identified from routine histological slides and the relative risk in patients with non-metastatic, conventional osteosarcoma is as high as other well known prognostic factors, including large size and poor chemotherapy effect.

Entities:  

Mesh:

Year:  2003        PMID: 14600127      PMCID: PMC1770098          DOI: 10.1136/jcp.56.11.831

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

2.  Small cell osteosarcoma of bone. Review of 72 cases.

Authors:  H Nakajima; F H Sim; J R Bond; K K Unni
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

3.  Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.

Authors:  T Hasegawa; T Hirose; K Seki; K Hizawa; S Ishii; J Wakabayashi
Journal:  Cancer Detect Prev       Date:  1997

4.  Expression of HER2/erbB-2 correlates with survival in osteosarcoma.

Authors:  R Gorlick; A G Huvos; G Heller; A Aledo; G P Beardsley; J H Healey; P A Meyers
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior.

Authors:  K Okada; T Hasegawa; R Yokoyama
Journal:  Hum Pathol       Date:  2001-07       Impact factor: 3.466

6.  Osteosarcoma in preadolescent patients.

Authors:  M Rytting; P Pearson; A K Raymond; A Ayala; J Murray; A W Yasko; M Johnson; N Jaffe
Journal:  Clin Orthop Relat Res       Date:  2000-04       Impact factor: 4.176

7.  Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

Authors:  A J Provisor; L J Ettinger; J B Nachman; M D Krailo; J T Makley; E J Yunis; A G Huvos; D L Betcher; E S Baum; C T Kisker; J S Miser
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience.

Authors:  M Szendroi; Z Pápai; R Koós; T Illés
Journal:  J Surg Oncol       Date:  2000-02       Impact factor: 3.454

9.  Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.

Authors:  N Baldini; K Scotlandi; G Barbanti-Bròdano; M C Manara; D Maurici; G Bacci; F Bertoni; P Picci; S Sottili; M Campanacci
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

10.  Clinical relevance of Ki-67 expression in bone tumors.

Authors:  K Scotlandi; M Serra; M C Manara; D Maurici; S Benini; G Nini; M Campanacci; N Baldini
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.